The US-based creator of the “world’s first and only continuous intravenous [IV] site monitoring solution” has been granted market authorisation by the Saudi Food and Drug Authority (SFDA), it has been announced.
Virginia’s ivWatch – which received a US FDA clearance and CE mark for its SmartTouch disposable sensor last year – has just received a three-year Medical Device Marketing Authorization (...